Summary | |
---|---|
Symbol | LARP6 |
Name | La ribonucleoprotein domain family, member 6 |
Aliases | acheron; FLJ11196; ACHN; death-associated LA motif protein; La ribonucleoprotein domain family member 6; La- ...... |
Chromosomal Location | 15q23 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Cytoplasm Nucleus Note=Shuttles between the nucleus and the cytoplasm. |
Domain |
PF05383 La domain PF12901 SUZ-C motif |
Function |
Regulates the coordinated translation of type I collagen alpha-1 and alpha-2 mRNAs, CO1A1 and CO1A2. Stabilizes mRNAs through high-affinity binding of a stem-loop structure in their 5' UTR. This regulation requires VIM and MYH10 filaments, and the helicase DHX9. |
Biological Process |
GO:0006417 regulation of translation GO:0010608 posttranscriptional regulation of gene expression GO:0034248 regulation of cellular amide metabolic process |
Molecular Function | - |
Cellular Component | - |
KEGG | - |
Reactome | - |
Summary | |
---|---|
Symbol | LARP6 |
Name | La ribonucleoprotein domain family, member 6 |
Aliases | acheron; FLJ11196; ACHN; death-associated LA motif protein; La ribonucleoprotein domain family member 6; La- ...... |
Chromosomal Location | 15q23 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between LARP6 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | LARP6 |
Name | La ribonucleoprotein domain family, member 6 |
Aliases | acheron; FLJ11196; ACHN; death-associated LA motif protein; La ribonucleoprotein domain family member 6; La- ...... |
Chromosomal Location | 15q23 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of LARP6 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | LARP6 |
Name | La ribonucleoprotein domain family, member 6 |
Aliases | acheron; FLJ11196; ACHN; death-associated LA motif protein; La ribonucleoprotein domain family member 6; La- ...... |
Chromosomal Location | 15q23 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of LARP6 in various data sets.
|
Points in the above scatter plot represent the mutation difference of LARP6 in various data sets.
|
Summary | |
---|---|
Symbol | LARP6 |
Name | La ribonucleoprotein domain family, member 6 |
Aliases | acheron; FLJ11196; ACHN; death-associated LA motif protein; La ribonucleoprotein domain family member 6; La- ...... |
Chromosomal Location | 15q23 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of LARP6. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | LARP6 |
Name | La ribonucleoprotein domain family, member 6 |
Aliases | acheron; FLJ11196; ACHN; death-associated LA motif protein; La ribonucleoprotein domain family member 6; La- ...... |
Chromosomal Location | 15q23 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of LARP6. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by LARP6. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | LARP6 |
Name | La ribonucleoprotein domain family, member 6 |
Aliases | acheron; FLJ11196; ACHN; death-associated LA motif protein; La ribonucleoprotein domain family member 6; La- ...... |
Chromosomal Location | 15q23 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of LARP6. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | LARP6 |
Name | La ribonucleoprotein domain family, member 6 |
Aliases | acheron; FLJ11196; ACHN; death-associated LA motif protein; La ribonucleoprotein domain family member 6; La- ...... |
Chromosomal Location | 15q23 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of LARP6 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | LARP6 |
Name | La ribonucleoprotein domain family, member 6 |
Aliases | acheron; FLJ11196; ACHN; death-associated LA motif protein; La ribonucleoprotein domain family member 6; La- ...... |
Chromosomal Location | 15q23 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between LARP6 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | LARP6 |
Name | La ribonucleoprotein domain family, member 6 |
Aliases | acheron; FLJ11196; ACHN; death-associated LA motif protein; La ribonucleoprotein domain family member 6; La- ...... |
Chromosomal Location | 15q23 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting LARP6 collected from DrugBank database. |
There is no record. |